| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.057 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |